Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Nov 4;13(1):130.
doi: 10.1186/s13048-020-00731-7.

Therapeutic role of curcumin and its novel formulations in gynecological cancers

Mohammad Hossein Pourhanifeh  1 , Maryam Darvish  2 , Javad Tabatabaeian  3 , Mahboobeh Rabbani Fard  3 , Reza Mottaghi  4 , Mohammad Javad Azadchehr  5 , Moghaddaseh Jahanshahi  6 , Amirhossein Sahebkar  7   8 , Hamed Mirzaei  9
Affiliations
Review

Therapeutic role of curcumin and its novel formulations in gynecological cancers

Mohammad Hossein Pourhanifeh et al. J Ovarian Res. .

Abstract

Gynecological cancers are among the leading causes of cancer-associated mortality worldwide. While the number of cases are rising, current therapeutic approaches are not efficient enough. There are considerable side-effects as well as treatment resistant types. In addition, which all make the treatment complicated for afflicted cases. Therefore, in order to improve efficacy of the treatment process and patients' quality of life, searching for novel adjuvant treatments is highly warranted. Curcumin, a promising natural compound, is endowed with numerous therapeutic potentials including significant anticancer effects. Recently, various investigations have demonstrated the anticancer effects of curcumin and its novel analogues on gynecological cancers. Moreover, novel formulations of curcumin have resulted in further propitious effects. This review discusses these studies and highlights the possible underlying mechanisms of the observed effects.

Keywords: Cervical cancer; Curcumin; Curcumin derivatives; Endometrial cancer; Nanocurcumin; Natural compound; Ovarian cancer.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflict of interest to disclose.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Li Y, Kong D, Wang Z, Sarkar FH. Regulation of microRNAs by natural agents: an emerging field in chemoprevention and chemotherapy research. Pharm Res. 2010;27(6):1027–1041. doi: 10.1007/s11095-010-0105-y. - DOI - PMC - PubMed
    1. Reuter S, Gupta SC, Park B, Goel A, Aggarwal BB. Epigenetic changes induced by curcumin and other natural compounds. Genes Nutr. 2011;6(2):93–108. doi: 10.1007/s12263-011-0222-1. - DOI - PMC - PubMed
    1. Vallianou NG, Evangelopoulos A, Schizas N, Kazazis C. Potential anticancer properties and mechanisms of action of curcumin. Anticancer Res. 2015;35(2):645–651. - PubMed
    1. Teymouri M, Pirro M, Johnston TP, Sahebkar A. Curcumin as a multifaceted compound against human papilloma virus infection and cervical cancers: A review of chemistry, cellular, molecular, and preclinical features. BioFactors. 2017;43(3):331–346. doi: 10.1002/biof.1344. - DOI - PubMed
    1. Miriyala S, Panchatcharam M, Rengarajulu P. Cardioprotective effects of curcumin. Adv Exp Med Biol. 2007;595:359–377. doi: 10.1007/978-0-387-46401-5_16. - DOI - PubMed

LinkOut - more resources